INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Zydus Lifesciences Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 532321	ISIN Demat INE010B01027	Book Value 215.08	NSE Symbol ZYDUSLIFE	Dividend Yield (%) 1.18	Market Cap (₹ Cr.) 93,484.17	P/E 19.37	EPS 47.96	Face Value 1

Particulars (₹ Cr)	Sep 2025	Jun 2025	Mar 2025	Dec 2024

Gross Sales/Income from operations	2808.8	2495.8	5633.5	2408.9
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	2,808.80	2,495.80	5,633.50	2,408.90
Other Operating Income	62.40	92.50	186.10	107.00
Total Income from operations (net)	2,871.20	2,588.30	5,819.60	2,515.90
Total Expenses	1,855.30	2,132.90	2,174.90	1,999.00
Cost of Sales	843.00	903.80	690.20	935.70
Employee Cost	468.70	487.20	476.30	425.00
Depreciation, amortization and depletion expense	136.00	130.00	128.00	131.60
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	407.60	611.90	880.40	506.70
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	1,015.90	455.40	3,644.70	516.90
Other Income	541.50	157.10	185.40	77.50
Profit from ordinary activities before finance costs and exceptional items	1,557.40	612.50	3,830.10	594.40
Finance Costs	113.80	137.60	155.40	97.20
Profit from ordinary activities after finance costs but before exceptional items	1,443.60	474.90	3,674.70	497.20
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	1,443.60	474.90	3,674.70	497.20
Total Tax	287.00	90.20	861.00	26.60
Net profit from Ordinary Activities After Tax	1,156.60	384.70	2,813.70	470.60
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	1,156.60	384.70	2,813.70	470.60
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	1,156.60	384.70	2,813.70	470.60
Other Comprehensive Income	16.20	1.00	11.20	-3.20
Total Comprehensive Income	1,172.80	385.70	2,824.90	467.40
Equity	100.60	100.60	100.60	100.60
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	11.49	3.82	27.96	4.68
EPS before Exceptional/Extraordinary items-Diluted	11.49	3.82	27.96	4.68
EPS after Exceptional/Extraordinary items-Basic	11.49	3.82	27.96	4.68
EPS after Exceptional/Extraordinary items-Diluted	11.49	3.82	27.96	4.68
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00